Ballentine Partners LLC boosted its holdings in shares of Relx Plc (NYSE:RELX – Free Report) by 14.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 19,785 shares of the technology company’s stock after acquiring an additional 2,479 shares during the quarter. Ballentine Partners LLC’s holdings in Relx were worth $899,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently bought and sold shares of RELX. JPMorgan Chase & Co. increased its stake in Relx by 14.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock valued at $39,225,000 after buying an additional 104,999 shares during the period. CWA Asset Management Group LLC acquired a new position in shares of Relx in the third quarter worth $548,000. Creative Planning raised its holdings in shares of Relx by 16.4% during the second quarter. Creative Planning now owns 128,930 shares of the technology company’s stock worth $5,915,000 after acquiring an additional 18,199 shares in the last quarter. International Assets Investment Management LLC acquired a new stake in Relx during the third quarter valued at $1,268,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Relx by 13.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock valued at $5,709,000 after purchasing an additional 14,088 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.
Wall Street Analysts Forecast Growth
RELX has been the subject of several research reports. Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They set a “buy” rating for the company. StockNews.com started coverage on shares of Relx in a research report on Wednesday, October 30th. They issued a “hold” rating for the company.
Relx Trading Down 0.6 %
Shares of NYSE:RELX opened at $49.24 on Thursday. The business has a 50-day moving average of $46.51 and a two-hundred day moving average of $46.63. Relx Plc has a fifty-two week low of $40.25 and a fifty-two week high of $49.57. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63.
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
See Also
- Five stocks we like better than Relx
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Oracle Announces Game-Changing News for the AI Industry
- What is the Dogs of the Dow Strategy? Overview and Examples
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is a SEC Filing?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.